葉黃素 Lutein

INT-lutein-001 3 個適應症被研究
B 2 C 1

適應症與證據等級

法規與權威立場 (L4)

L4a · US FDA
立場:supportive
FDA has no questions; some uses may require a color additive listing
來源 ↗
L4b · EU EFSA
立場:against
L4c · UK NHS
立場:against
Prescribers should not initiate lutein and antioxidants for any new patient, and patients currently being prescribed these products should be reviewed and treatment stopped.
來源 ↗
L4d · TW TFDA / 衛福部
立場:neutral
膠囊錠狀食品中每日食用量標示者,每人每日葉黃素食用量不得超過30毫克;未標示每日食用量者,每300公克中葉黃素含量不得超過9毫克。
來源 ↗
L4e · WHO
立場:not_addressed
Based on the absence of toxicity in a wide range of studies, the Committee at its 86th meeting established a group ADI 'not specified' for lutein from Tagetes erecta, lutein esters from Tagetes erecta and zeaxanthin (synthetic). The decision was based on the absence of any observed toxicity of lutein or lutein esters in toxicological studies in animals, the absence of any adverse effects in hum…
來源 ↗

市場與行銷 (L10)

L10a · TW Market Channels
游離型葉黃素 大研視易適 NT$35/日
L10b · TW Legal Identity (TFDA)
限於補充食品中不足之營養素時使用
L10c · TW Community (PTT/Dcard/Mobile01)
葉黃素又不是仙丹